BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $600 From $530, Maintains Outperform Rating
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Vertex, Inc. $VERX Stock Position Lifted by Vanguard Group Inc.
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Vertex Insider Sales Contrast With Analyst Targets And Valuation Signals
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Here’s What Analysts Are Saying About Vertex Pharmaceuticals (VRTX)
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Vertex to Present at Upcoming Conferences
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Gemini 3.1 Pro on Gemini CLI, Gemini Enterprise, and Vertex AI
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.